MEDIUM TERM EFFICACY AND SAFETY OF ADALIMUMAB THERAPY IN PATIENTS WITH CROHN'S DISEASE. NATIONAL DATA FROM HUNGARY

(1) Department of Gastroenterology, State Health Centre

(2) 2nd Department of Medicine, Semmelweis University, Budapest

(3) 1st Department of Medicine, Csolnoky F. County Hospital, Veszprem

(4) Department of Gastroenterology, Szekszard County Hospital, Szekszard

(5) 1st Department of Medicine, University of Szeged, Szeged

(6) 1st Department of Medicine, University of Pecs, Pecs

(7) 2nd Department of Medicine, University of Debrecen, Debrecen

(8) Department of Internal Medicine, Miskolc County Hospital, Miskolc

(9) 1st Department of Medicine, Semmelweis University, Budapest, Hungary



This item was part of the IMMFLAMMATORY BOWEL DISEASE II session at Gastro 2009 UEGW/WCOG London (17th UEGW)